Navigation Links
New Study Confers All Clear Status On Letrozole, Infertility Drug

Concerns about increased risk of birth defects associated with letrozole, a cost effective and an easy to use drug, commonly given for infertility treatment has been settled//. A new research has now established that the rate of birth defects associated with letrozole is very similar to that associated with clomiphene citrate, the first line treatment for infertility for more than 40 years that is associated with a low risk.

The researchers examined nearly 911 newborns who were treated for infertility with either clomiphene citrate or letrozole between 2001 and 2005.Babies of mothers treated with letrozole and clomiphene citrate had the same rate of incidence of birth defects.

The results of this study, which contradicts earlier studies linking letrozole to increased rates of inherited malformations, appear in the online version of Fertility and Sterility.

The drug letrozole has been increasingly used in infertility treatment in the recent years. No statistically significant difference in the incidence of minor/major birth defects or other chromosome abnormalities in newborns has been documented by the study. This highlights that letrozole can indeed be used in infertility treatment without increased birth defect risk to the fetus.

The reports of increased birth defects associated with use of the drug in earlier studies could be due to fault in the methodology. The previous studies compared the incidence of birth defects in children conceived through fertility treatments using letrozole and spontaneously conceived children. This equates to an oranges- and-apples comparison, as natural conception is always associated with a low risk of birth defects. In addition, previous studies had not taken care to include age-matched control and treatment groups.


'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to lead ... reduce waste, and support renewable energy. They believe this is a crucial part of ... solutions for health issues, and maintain that destroying the environment in the pursuit of ...
(Date:4/24/2017)... ... ... , a national non-profit organization focusing on the prevention and early detection of breast and ... to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay Avner ... Board and launched a national search to find a visionary new leader to grow Bright ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health and ... to track their cognitive health, and share results with their physicians. Members and guests ... the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick ... Available 24 hours a day, Quick Care provides patients with the option to ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management announced today ... people with addiction who are served by MAP’s patient engagement ecosystem. Lief Therapeutics ... monitors heart and breath rates to identify anxiety levels and can provide biofeedback ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: